CD274 and neoplasm: Evaluation of PD-L1 expression with the 22C3 and 28-8 pharmDx, as well as SP263 (Ventana) assays, only refers to the PD-L1 expression on tumor cells, while, on the other hand, the SP142 (Ventana) assay refers to tumor and immune cells staining [109].